After gaining resounding creditor support, Purdue Pharma's settlement plan now needs to secure court approval.

All 50 states as well as Washington, D.C., and four U.S. territories have agreed to sign a $7.4 billion settlement with the company and once-prominent family behind OxyContin, officials announced ...

This is an archived article and the information in the article may be outdated. Please look at the time stamp on the story to see when it was last updated. The attorneys general for eight holdout ...

Purdue Pharma LP agreed to plead guilty to criminal charges over the handling of its addictive prescription opioid OxyContin, ...

Two members of the wealthy Sackler family who own OxyContin maker Purdue Pharma LP offered apologies on Thursday for the role the prescription painkiller has played in the deadly U.S. opioid epidemic ...

The Supreme Court on Thursday blew up the massive bankruptcy reorganization of opioid maker Purdue Pharma, finding that the settlement inappropriately included legal protections for the Sackler family ...

The city is set to receive $48 million from a settlement with Purdue Pharma and its former owners, the Sackler family, for their role in producing and marketing highly addictive opioids. Mayor Eric ...

In Harrington v. Purdue Pharma L.P., the Supreme Court issued a landmark ruling holding that “the bankruptcy code does not authorize a release and injunction that, as part of a plan of reorganization ...

The $7.4 billion settlement plan proposed by OxyContin maker Purdue Pharma and the Sackler family members who own the bankrupt firm has gained nearly unanimous creditor approval. More than 54,000 ...